The aim of this study was to understand the relation between changes in behavior and mental health during the early phase of the first wave of the COVID-19 pandemic in the United States during April and May, 2020.
Impaired quality of life in people following hypoparathyroidism surgery and treatment is increasingly acknowledged. Researchers analyzed this with a questionnaire.
While depression is a common psychiatric disorder, the underlying biological basis isn’t quite understood. Researchers sought to pair depression polygenic scores with the results of clinical laboratory tests in an attempt to reveal the biological processes involved in depression etiology and in the physiological changes resulting from depression.
In a case-control study, researchers assessed risk factors for persistent neuropathic pain in those who have recovered from COVID-19 and observed their serum level of neurofilament light chain.
The prevalence of depression is increased among pediatric and adult patients with hidradenitis suppurativa (HS).
The utility of the Two Questions Test as a screening tool in patients with psoriasis is examined.
In this study, patients were stratified by condition and suicide history and randomized to receive 600 mg/d extended-release lithium carbonate or placebo in addition to usual care.
Researchers sought to investigate the association between lower retinal nerve fiber layer thickness, a marker of neurodegeneration, with clinically relevant depressive symptoms and depressive symptoms over time.
For patients with newly diagnosed breast cancer, tailored strategies for implementation of routine depression screening result in a greater proportion of referrals to behavioral care.
With microdosing gaining popularity for its positive effects on wellness and cognition, researchers studied microdosing practices, motivations, and mental health among microdosers and non-microdosers.
